152 related articles for article (PubMed ID: 22964583)
1. Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Hartikainen JM; Tengström M; Kosma VM; Kinnula VL; Mannermaa A; Soini Y
Cancer Res; 2012 Nov; 72(21):5537-46. PubMed ID: 22964583
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study.
Kunnas T; Määttä K; Nikkari ST
Int J Med Sci; 2016; 13(5):325-9. PubMed ID: 27226772
[TBL] [Abstract][Full Text] [Related]
3. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
4. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Seibold P; Hall P; Schoof N; Nevanlinna H; Heikkinen T; Benner A; Liu J; Schmezer P; Popanda O; Flesch-Janys D; Chang-Claude J
Breast; 2013 Oct; 22(5):817-23. PubMed ID: 23489758
[TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin-1 attenuates oxidative stress via Nrf2/ARE pathway and 2-Cys Prdxs after oxygen-glucose deprivation in astrocytes.
Zhou Y; Duan S; Zhou Y; Yu S; Wu J; Wu X; Zhao J; Zhao Y
J Mol Neurosci; 2015 Apr; 55(4):941-50. PubMed ID: 25407820
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.
Soini Y; Eskelinen M; Juvonen P; Kärjä V; Haapasaari KM; Saarela A; Karihtala P
Pathol Res Pract; 2014 Jan; 210(1):35-9. PubMed ID: 24189098
[TBL] [Abstract][Full Text] [Related]
8. A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure.
Bischoff LJM; Kuijper IA; Schimming JP; Wolters L; Braak BT; Langenberg JP; Noort D; Beltman JB; van de Water B
Arch Toxicol; 2019 Feb; 93(2):435-451. PubMed ID: 30456486
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Merikallio H; Pääkkö P; Kinnula VL; Harju T; Soini Y
Hum Pathol; 2012 Apr; 43(4):577-84. PubMed ID: 21943684
[TBL] [Abstract][Full Text] [Related]
10. Sulfiredoxin-1 enhances cardiac progenitor cell survival against oxidative stress via the upregulation of the ERK/NRF2 signal pathway.
Li X; He P; Wang XL; Zhang S; Devejian N; Bennett E; Cai C
Free Radic Biol Med; 2018 Aug; 123():8-19. PubMed ID: 29772252
[TBL] [Abstract][Full Text] [Related]
11. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
12. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer.
Hong CC; Ambrosone CB; Ahn J; Choi JY; McCullough ML; Stevens VL; Rodriguez C; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1784-94. PubMed ID: 17726138
[TBL] [Abstract][Full Text] [Related]
14. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.
Seng S; Avraham HK; Jiang S; Yang S; Sekine M; Kimelman N; Li H; Avraham S
Cancer Res; 2007 Sep; 67(18):8596-604. PubMed ID: 17875699
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
16. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
17. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
[TBL] [Abstract][Full Text] [Related]
18. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard.
Tahmasbpour Marzony E; Ghanei M; Panahi Y
Exp Lung Res; 2016 May; 42(4):217-26. PubMed ID: 27266564
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking is associated with human semen quality in synergy with functional NRF2 polymorphisms.
Yu B; Chen J; Liu D; Zhou H; Xiao W; Xia X; Huang Z
Biol Reprod; 2013 Jul; 89(1):5. PubMed ID: 23718983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
